A Fact Sheet for Vaccine Providers published on the Food and Drug Administration (FDA) website admits that “Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.” The Fact Sheet was issued in response to the FDA granting an emergency use authorization for the Pfizer vaccine for people aged 12 and older. The Fact Sheet also notes that the Pfizer vaccine carries risk of the heart conditions myocarditis and pericarditis in addition to numerous other ailments that have been reported in clinical trials, and that “immunocompromised persons…may have a diminished immune response to the Pfizer-BioNTech COVID-19 Vaccine.” Recent former FDA commissioner Scott Gottlieb (pictured above) is now on the board of directors of Pfizer. A contingent of recent Pfizer workers who serve on an FDA advisory committee are trying to get the FDA to authorize a Pfizer vaccine for children aged 5 to 11.
The fact sheet for the vaccine for people aged 12 and up is also published on the PFIZER LABELING website and it states: “Postmarketing data demonstrate increased risks of myocarditis and pericarditis, particularly within 7 days following the second dose. The observed risk is higher among males under 40 years of age than among females and older males. The observed risk is highest in males 12 through 17 years of age. Although some cases required intensive care support, available data from short-term follow-up suggest that most individuals have had resolution of symptoms with conservative management. Information is not yet available about potential long-term sequelae.”
“Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer-BioNTech COVID-19 Vaccine,” according to the Fact Sheet promoted by the FDA.
“Adverse reactions following the Pfizer-BioNTech COVID-19 Vaccine that have been reported in clinical trials include injection site pain, fatigue, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, malaise, lymphadenopathy, and decreased appetite,” Pfizer states.
Pfizer adds: “Severe allergic reactions, including anaphylaxis, and other hypersensitivity reactions (e.g., rash, pruritus, urticaria, angioedema), diarrhea, vomiting, pain in extremity (arm), and syncope have been reported following administration of the Pfizer-BioNTech COVID-19 Vaccine outside of clinical trials. Myocarditis and pericarditis have been reported following administration of the Pfizer-BioNTech COVID-19 Vaccine outside of clinical trials. Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine,” according to the Fact Sheet promoted by the FDA.
